Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Key Takeaways Retatrutide is a triple agonist binding GIP, GLP-1 and glucagon receptors simultaneously, a mechanism absent from all MHRA-authorised incretin therapies The 32mg pen format minimises wastage in early-phase protocols and supports typical titration schedules from 0.5mg to 4mg per administration Every unit ships with batch-level traceability, HPLC purity documentation and a certificate of analysis Retatrutide holds no MHRA marketing authorisation and is supplied strictly for laboratory research use UK orders ship free via tracked Royal Mail within 13 working days
Many people incorporate it into their daily routines for various health and wellness goals
Advertising or spam is also prohibited.
When it comes to regulation and compliance, you want to choose a product that is certified and patented with proven scientific results
Cellular Support: Astaxanthin helps protect cellular phospholipid membranes from oxidative damage
This product is strictly intended for in vitro and preclinical laboratory research
US$ 23.47
US$ 20.01
US$ 29.19
US$ 25.48
US$ 28.64
US$ 20.81
US$ 28.94
